| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Life Sciences Tools & Services (Health Care sector), EXAS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.40M | - | - | |
| VP | 191.9K | - | - | |
| VP | 153.7K | - | - | |
| CFO | 138.7K | - | - | |
| VP | 137.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2018 | Coward D Scott77 | SVP And General Counsel | Sale+OE | 2,122 | $40.12 | $85,124.03 | -3.1% | |
| Mar 13, 2018 | Lidgard Graham Peter | Chief Science Officer | Sale+OE | 14,550 | $51.98 | $756,271.25 | -2.4% | |
| Mar 12, 2018 | Coward D Scott77 | SVP And General Counsel | Sale+OE | 2,708 | $52.19 | $141,341.35 | -4.0% | |
| Mar 12, 2018 | Conroy Kevin T81 | President And CEO | Sale+OE | 11,459 | $52.19 | $598,091.05 | -1.3% | |
| Mar 12, 2018 | Arora Maneesh | COO | Sale+OE | 5,295 | $52.19 | $276,367.23 | -0.8% | |
| Feb 27, 2018 | Arora Maneesh | COO | Sale+OE | 5,512 | $44.10 | $243,068.18 | -0.9% | |
| Feb 27, 2018 | Lidgard Graham Peter | Chief Science Officer | Sale+OE | 35,025 | $42.88 | $1,501,960.29 | -4.1% | |
| Feb 27, 2018 | Coward D Scott77 | SVP And General Counsel | Sale+OE | 9,292 | $44.10 | $409,758.62 | -13.2% | |
| Feb 27, 2018 | Conroy Kevin T81 | President And CEO | Sale+OE | 9,085 | $44.10 | $400,630.33 | -1.0% | |
| Feb 26, 2018 | Lidgard Graham Peter | Chief Science Officer | Sale+OE | 27,428 | $40.44 | $1,109,266.16 | -4.2% |